Samsung Bio "Diversifying Business and Expanding Global Bases to Leap into Comprehensive Bio"
[Asia Economy Reporter Cho Hyun-ui] Samsung Biologics announced that it will challenge the new drug business beyond contract manufacturing (CMO) and contract development (CDO) of biopharmaceuticals to leap forward as a global integrated bio company.
John Rim, CEO of Samsung Biologics, made this statement while announcing the mid- to long-term plan for the next 10 years at the 39th JP Morgan Healthcare Conference on the 13th (local time).
CEO John Rim said, "The past 10 years focused on stabilizing the business and rapidly expanding production scale," adding, "For the next 10 years, we will leap forward as a global integrated bio company by expanding production scale, business portfolio, and global bases."
Samsung Biologics is currently constructing its 2nd Bio Campus, spanning 100,000 pyeong, in Songdo, Incheon. Following the establishment of a CDO research and development (R&D) center in San Francisco, USA last year, it plans to sequentially expand into Boston, USA, Europe, China, and other regions.
Additionally, by strengthening open innovation, it plans to invest in new pipelines and platform technologies and expand its existing antibody drug-centered business structure to include cell therapies and vaccines. While solidifying its champion position in the existing CDO·CMO and biosimilar fields, it is also considering entering the new drug business.
Samsung Biologics plans to proceed smoothly with the construction of its 4th plant this year and focus on securing early orders. It aims to maintain its superiority in the European biosimilar market and target major global markets such as the United States.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- "Why This Bonus Grade?" Civil Servant Who Assaulted HR Employee... Court Rules Demotion Is Justified
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
CEO John Rim said, "Last year, we successfully achieved our goals in all business sectors," adding, "In the case of CMO, we recorded the highest order performance ever last year." He continued, "CDO orders have continuously increased, and the annual project capacity has also greatly expanded," evaluating that "it has successfully settled in the market within three years of starting the business."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
